Gholam A. Peyman, M.D., Joins InSite Vision (ISV)’s Scientific Advisory Board
3/27/2013 7:04:26 AM
Site Vision Incorporated (OTCBB: INSV) today announced that Dr. Gholam A. Peyman has joined its Scientific Advisory Board (SAB) which helps to guide and shape the InSite Vision research programs in the development of novel ophthalmic medicines. Members of the SAB are leaders in ophthalmic research, treatment and clinical drug development and include Richard Lindstrom, M.D., Gary Foulks, M.D., Michael Lemp, M.D., and Kelly Nichols, O.D., M.P.H., Ph.D. Kamran Hosseini, M.D., Ph.D., InSite’s Chief Medical Officer, is the leader of the SAB and Brian Levy, O.D., a member of InSite’s Board of Directors participates in all SAB meetings.
comments powered by